Literature DB >> 31335544

Mission Impossible or Mission Futile?: Estimating Penetrance for Malignant Hyperthermia.

Marie-Anne Shaw1, Philip M Hopkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31335544     DOI： 10.1097/ALN.0000000000002884

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  4 in total

Review 1.  Genomic Screening for Malignant Hyperthermia Susceptibility.

Authors:  Leslie G Biesecker; Robert T Dirksen; Thierry Girard; Philip M Hopkins; Sheila Riazi; Henry Rosenberg; Kathryn Stowell; James Weber
Journal:  Anesthesiology       Date:  2020-12-01       Impact factor: 7.892

Review 2.  Anaesthetic management of a known or suspected malignant hyperthermia susceptible patient.

Authors:  P K Gupta; J G Bilmen; P M Hopkins
Journal:  BJA Educ       Date:  2021-02-19

3.  Ryanodine receptor 1 (RYR1) mutations in two patients with tubular aggregate myopathy.

Authors:  Gaetano Nicola Alfio Vattemi; Daniela Rossi; Lucia Galli; Maria Rosaria Catallo; Elia Pancheri; Giulia Marchetto; Barbara Cisterna; Manuela Malatesta; Enrico Pierantozzi; Paola Tonin; Vincenzo Sorrentino
Journal:  Eur J Neurosci       Date:  2022-06-13       Impact factor: 3.698

4.  Sevoflurane may not be a complete sigh of relief in COVID-19.

Authors:  Vikas Kaura; Philip M Hopkins
Journal:  Br J Anaesth       Date:  2020-09-16       Impact factor: 9.166
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.